Table 1. Demographic and clinical characteristics of the 32 HIV/HCV coinfected patients by immunological response to HAART.
| Characteristics | Immunological Responders | Non-responders | ||
| N. (%) | 20 | (62.5%) | 12 | (37.5%) |
| Mean age (years) | 49.8 | 48.9 | ||
| Male:female | 15:5 | 9:3 | ||
| Mean CD4 baseline (±SD) | 106.9 | (110.1) | 194.9 | (152.3) |
| Mean CD4 end * (±SD) | 376.3 | (213.7) | 257.7 | (178.2) |
| Mean CD8 baseline (±SD) | 821.3 | (733.4) | 854.9 | (431.1) |
| Mean CD8 end (±SD) | 1255.6 | (686.0) | 1003.4 | (341.8) |
| Mean CD19 baseline (±SD) | 216.8 | (314.2) | 139.0 | (151.4) |
| Mean CD19 end (±SD) | 628.6 | (397.4) | 501.7 | (168.2) |
| Genotype 1 N. (%) | 8 | (61.5%) | 3 | (42.9%) |
| Genotype 3 N. (%) | 4 | (30.8%) | 3 | (42.9%) |
| Genotype 4 N. (%) | 1 | (7.7%) | 1 | (14.3) |
| HCV viremia baseline (±SD) | 1.59 | (1.4) | 1.9 | (1.4) |
| HCV viremia end (±SD) | 2.25 | (1.2) | 1.7 | (1.2) |
*end of follow-up.
CD4, CD8, CD19 cell counts are expressed in cells/µl.
N.: number.